Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  T2 Biosystems Inc    TTOO

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/18/2017 09/19/2017 09/20/2017 09/21/2017 09/22/2017 Date
4.6(c) 4.45(c) 4.26(c) 4.16(c) 4.29(c) Last
513 325 333 991 328 507 181 742 131 223 Volume
+1.77% -3.26% -4.27% -2.35% +3.13% Change
More quotes
Financials ($)
Sales 2017 4,47 M
EBIT 2017 -54,0 M
Net income 2017 -60,4 M
Finance 2017 10,6 M
Yield 2017 -
Sales 2018 23,4 M
EBIT 2018 -45,0 M
Net income 2018 -56,8 M
Finance 2018 9,92 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 31,4x
EV / Sales2018 6,02x
Capitalization 151 M
More Financials
Company
T2 Biosystems, Inc. engages in the development of innovative and proprietary technology platform.It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood,... 
Sector
Medical Equipment, Supplies & Distribution
Calendar
09/25 | 04:55pmPresentation
More about the company
Surperformance© ratings of T2 Biosystems Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on T2 BIOSYSTEMS INC
09/21 T2 Biosystems Announces Presentations at IDWeek 2017
09/19 T2 BIOSYSTEMS, INC. : Entry into a Material Definitive Agreement, Financial Stat..
09/18 T2 Biosystems to Present at the Cantor Fitzgerald Global Healthcare Conferenc..
09/16 T2 BIOSYSTEMS : Announces Pricing of Public Offering of Common Stock
09/15 T2 BIOSYSTEMS : Announces Proposed Public Offering of Common Stock
09/15 T2 Biosystems Announces Pricing of Public Offering of Common Stock
09/14 T2 BIOSYSTEMS : announces three major developments They're partnering with the C..
09/14 T2 BIOSYSTEMS, INC. (NASDAQ : TTOO) Files An 8-K Financial Statements and Exhibi..
09/14 T2 BIOSYSTEMS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
09/14 T2 Biosystems Announces Proposed Public Offering of Common Stock
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
09/20 ESSILOR INTERNATIONAL : Luxottica, Essilor offer no merger concessions to EU reg..
09/19DJTEVA PHARMACEUTICAL INDUSTRIES : Sells Women's Health Assets -- WSJ
09/18DJTEVA PHARMACEUTICAL INDUSTRIES : Sells Slate of Women's Health Products in Debt-..
09/13 Apple suppliers dent European shares as rally flags
09/12DJMARKET SNAPSHOT : Stock Market Heads To Records As Investors Await Apple Device ..
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
09/22Financial Survey: Invacare Corporation $IVC & T2 Biosystems $TTOO  
09/21T2 Biosystems Announces Presentations at IDWeek 2017 -
1
09/21T2 Biosystems Announces Presentations at IDWeek 2017  
09/21T2 Biosystems Announces Presentations at IDWeek 2017  
09/18T2 Biosystems to Present at the Cantor Fitzgerald Global Healthcare Conferenc.. 
More tweets
Qtime:18
News from SeekingAlpha
09/15 Midday Gainers / Losers
09/15 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
09/15 PREMARKET LOSERS AS OF 9 : 05 am
09/15 T2 Bio prices stock offering at $4; shares down 31% premarket
09/14 After Hours Gainers / Losers
Chart T2 BIOSYSTEMS INC
Duration : Period :
T2 Biosystems Inc Technical Analysis Chart | TTOO | US89853L1044 | 4-Traders
Technical analysis trends T2 BIOSYSTEMS INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 5,00 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
John P. McDonough President, Chief Executive Officer & Director
Joanne Spadoro Chief Operating Officer
Darlene M. Deptula-Hicks Chief Financial Officer, Senior VP & Treasurer
Thomas Jay Lowery Chief Scientific Officer
Michael A. Pfaller Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
T2 BIOSYSTEMS INC-19.01%151
MEDTRONIC PLC12.54%107 961
BAXTER INTERNATIONAL42.94%34 605
C R BARD INC41.27%23 155
ZIMMER BIOMET HOLDINGS INC9.55%23 131
HOYA CORPORATION23.29%21 111